Navigation Links
PuraMed BioScience, Inc. Announces LipiGesic®M, Their Unique Migraine Treatment, is Now Available for Purchase at CVS, the 2nd Largest Drug Chain in the United States
Date:1/25/2012

SCHOFIELD, Wis., Jan. 25, 2012 /PRNewswire/ -- PuraMed BioScience, Inc. (OTCBB: PMBS) announced today that LipiGesic M, their clinically proven effective and safe, all natural product for the treatment of migraine headaches, is now available for purchase at CVS, the 2nd Largest Drug Chain in the United States. With the addition of over 7,000 CVS locations, LipiGesic®M is now available in approximately 15,000 stores nationwide.

"We are pleased to now have our LipiGesic®M product available in both the #1 and #2 Drug Chain stores in the United States.  Between the nearly 8,000 Walgreens and 7,000 CVS locations nationwide, we believe our product is gaining the exposure needed to generate significant revenue," stated Russ Mitchell, CEO of PuraMed BioScience.

PuraMed BioScience, Inc. anticipates announcing additional distribution in chain drug stores in the near future.

About PuraMed BioScience, Inc.:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products.  PuraMed has completed a double blind placebo clinical trial for its leading product, LipiGesic®M, a sublingual acute treatment for the relief from migraine headaches, which was published in the top-tier medical journal, Headache. Please see the following link to view the abstract of that study.  http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01910.x/abstract.  LipiGesic®M has national distribution and is available nationwide in some of the largest chain drug stores in the United States.  In addition to LipiGesic®M, the Company also has plans to launch LipiGesic®H for tension-type headaches as well as LipiGesic®PM which provides a remedy for insomnia and other sleep disorders.

For more information on PuraMed, visit the Company website at www.PuraMedBioScience.com, and join the Company's group page on Facebook by searching "PuraMed BioScience."

Forward-Looking Statements:  
This news release contains forward-looking statements regarding PuraMed BioScience and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact:
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO
715-359-6373
rmitchell@PuramedBioScience.com
www.PuramedBioScience.com

Investor Relations:
Investor Awareness, Inc.
Tony Schor or James Foy
847-945-2222
www.investorawareness.com


'/>"/>
SOURCE PuraMed BioScience, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PuraMed BioScience, Inc. Has Its Lead Product, LipiGesic®M Featured in Flaherty Financial News
2. Crown Bioscience, Inc. Announces Closing of Series C Financing
3. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
4. Integware Announces Systems Integrator Agreement With Siemens PLM Software
5. Millennium Research Institute Announces 2012 Educational Initiatives
6. Tris Pharma Announces Appointment of Dr. Mahdi Fawzi as Top R&D Executive
7. Jazz Pharmaceuticals plc Announces New Executive Appointments
8. BD Announces Webcast of Annual Meeting of Shareholders
9. Codexis Announces CFO Departure
10. Elanco Animal Health Announces Lillys Agreement to Acquire ChemGen Corp.
11. Span-America Announces First Quarter Conference Call on the Internet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)...  Amy Baxter MD, chief executive officer and founder ... relief, was awarded a 2017 Top 40 Healthcare Transformer ... at the MM&M Top 40 Healthcare Transformers dinner and ... on May 10, 2017. The dinner followed a full-day ... the pill."  "Innovation goes beyond invention," noted ...
(Date:5/10/2017)... Global Health Intelligence (GHI), the leading ... , published its 2017 ranking of the Best-Equipped Hospitals ... data analysis from GHI,s hospitals database for Latin America ... region. The GHI database covers 86% of the hospitals in ... data points for each institution in key areas such as ...
(Date:5/9/2017)... , May 9, 2017  Demonstrating its ... board of directors for the Pharmaceutical Research and ... for membership. Biopharmaceutical companies will now have to ... order to be eligible to join PhRMA. ... the board is sending a clear message that ...
Breaking Medicine Technology:
(Date:5/21/2017)... ... 2017 , ... Chris Cornell, 52, was found dead on the night of Wednesday, May 17, ... lead singers in the rock industry would take his own life, but the extremely talented ... mental illness played a role in the death of Chris Cornell . , Depression ...
(Date:5/21/2017)... (PRWEB) , ... May 20, 2017 , ... Pot. Reefer. ... find it, review it, and share its attributes like never before. More than a ... to connect cannabis enthusiasts to stores, strains, products – and for the first time ...
(Date:5/21/2017)... ... ... Following the tragic and widely publicized death of Rory Staunton, 12, from ... follow a protocol to quickly identify and treat the condition. , The mandate ... have saved Rory or anyone else’s life. , Now, five years after the ...
(Date:5/19/2017)... ... May 19, 2017 , ... ... an upcoming episode of Innovations with Ed Begley, Jr., airing fourth quarter 2017 ... distributor of a clean, organic dietary supplement made from naturally occurring ingredients. Innovations ...
(Date:5/19/2017)... ... May 19, 2017 , ... The Miller ... assistance to families and business owners in the region, is embarking on a ... sufferers and their families. , Multiple sclerosis (MS) is a demyelinating disease that ...
Breaking Medicine News(10 mins):